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ABSTRACT
Aim: Despite high pathogen burden and malnutrition in low-income settings, knowledge
on relationship between asymptomatic viral or parasitic infections, nutrition and growth is
insufficient. We studied these relationships in a cohort of six-month-old Malawian infants.
Methods: As part of a nutrient supplementation trial for 12 months, we documented
disease symptoms of 840 participant daily and anthropometric measurements every three
months. Stool specimens were collected every six months and analysed for Giardia
lamblia, Cryptosporidium species and enterovirus, rotavirus, norovirus, parechovirus and
rhinovirus using polymerase chain reaction (PCR). The prevalence of the microbes was
compared to the children’s linear growth and the dietary.
Results: The prevalence of the microbes was similar in every intervention group. All age
groups combined, children negative for G. lamblia had a mean standard deviation (SD) of
0.01 (0.49) change in length-for-age Z-score (LAZ), compared to 0.12 (0.045) among
G. lamblia positive children (difference 0.10, 95% CI 0.21 to 0.00, p = 0.047). The
LAZ change difference was also statistically significant (p = 0.042) at age of 18–
21 months but not at the other time points.
Conclusion: Asymptomatic G. lamblia infection was mainly associated with growth
reduction in certain three-month periods. The result refers to the chronic nature of
G. lamblia infection.
INTRODUCTION
Globally, linear growth failure or stunting affected an
estimated 154.8 million, 22.9% of under five-year-old
children in 2016 (1). Inadequate nutrition and intestinal
infections are considered to be the main causes of child-
hood stunting (2) but results from antibiotic and probiotic
interventions have been insufficient (3). In addition, Etiol-
ogy, Risk Factors and Interactions of Enteric Infections and
Malnutrition and the Consequences for Child Health and
Development (MAL-ED) study did not find diarrhoea to be
a major risk factor for poor growth. However, the study
identified asymptomatic enteropathogen burden as an
important contributor to growth faltering in children (4).
Giardia lamblia, also called as Giardia duodenalis or
Giardia intestinalis, and Cryptosporidium species are envi-
ronmentally ubiquitous protozoa and the most common
enteric parasites infecting humans worldwide (5). In low-
income countries, asymptomatic infections are very com-
mon, with prevalence values of, for example, giardiasis in
paediatric populations being typically around 30% (6). The
Abbreviations
CI, Confidence intervals; LAZ, Length-for-age Z-score; LNS,
Lipid-based nutrient supplementation; PCR, Real-time poly-
merase chain reaction; SD, Standard deviation; WHO, World
Health Organization; WLZ, Weight-for-length Z-score.
Key notes
 Few studies have addressed the association of asymp-
tomatic viral or parasitic infections and growth.
 We studied the epidemiology of two parasites and five
viruses among asymptomatic Malawian children at six
to 18 months of age and observed that primarily the
asymptomatic Giardia lamblia infection was associated
with subsequent growth reduction.
 To better assess the growth impact of non-chronic viral
infections, more sensitive outcome variables are rec-
ommended with short follow-up periods.
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prevalence of enteric pathogens or their consequences
without diarrhoea, particularly in young children, is still
poorly understood (7). However, it has been suggested that
acute infections impact the children’s linear growth through
a direct as enteric and indirect as respiratory pathways (8).
A primary aim of this study was to test whether the
prevalence of G. lamblia, Cryptosporidium species, enter-
ovirus, rotavirus, norovirus, parechovirus and rhinovirus,
detected in faecal samples among asymptomatic Malawian
children at age of six, 12 and 18 months, is associated with
linear growth reduction in the subsequent three-month
period. A secondary aim was to study if a dietary supple-
mentation would have an impact on the prevalence of the
studied microbes in the children’s stools.
SUBJECTS AND METHODS
Study design and specimen collection
This was a prospective cohort study, nested in a clinical
Lungwena Child Nutrition Intervention Study (LCNI-5)
registration ID: NCT00524446, assessing the effect of
dietary supplementation with lipid-based nutrient supple-
ments (LNS) on early childhood growth (9). The trial was
conducted in Lungwena and Malindi, in two rural Malaw-
ian communities. Potentially eligible participants were
identified through community census in the study area
and invited to an enrolment session, where infants were
screened for eligibility. The inclusion criteria included age
5.50–6.50 months, residence in the study area and informed
consent from an authorised guardian. The exclusion criteria
were weight-for-length Z-score (WLZ) <80% of the World
Health Organization (WHO) reference median or presence
of oedema, severe illness warranting hospitalisation on the
enrolment day, history of peanut allergy, concurrent par-
ticipation in another clinical trial and any symptoms of food
intolerance within 30 minutes after ingesting a five g test
dose of LNS used in the trial (9).
The study population was enrolled between 28 January
2008 and 25 May 2010 and comprised of 840 six-month-old
infants. After the enrolment, the participants were provided
with one of the four dietary for 12 months. Dietary
supplementation included either 54 g/day of milk or soy
containing LNS, 72 g/day fortified maize–soy flour or in a
control group, no extra food supplements.
The morbidity information was used to exclude those
participants having illness symptoms at collection time. We
collected data with picture calendar recorded by guardian.
The calendar had separate columns for the following
symptoms: fever, cough, diarrhoea and other. The recorded
information was reviewed and cross-checked by fieldwork-
ers at each two weekly food delivery visit for completeness.
From the information we collected at enrolment, 31
children had had diarrhoea within 14 days prior to stool
sample collection, 22 within seven days and 11 within two
days. This information describes the data reported before
the first (inclusion) sample was taken. Those participants
who did not have the symptoms and were healthy in their
guardians’ views comprised our study subjects.
Faecal samples were collected at child age of six, 12 and
18 months to detect the prevalence of the pathogens.
Guardians collected a faecal sample from the participants
at each time point and brought the sample in a 30 mL stool
container to the health centre. The time between defecation
and faecal freezing was not more than six hours. Bacterial
findings (10,11) and prevalence of selected viruses and
parasites and their predictors (12) in Malawian children as
part of the same nutritional trial have been reported earlier.
Now, we report viral and parasitic results in relation to
children’s growth and the nutrition interventions.
The trial adhered to the principles of the Declaration of
Helsinki and regulatory guidelines in Malawi. The research
and ethics committee of the College of Medicine, University
of Malawi and the ethical committee of the Pirkanmaa
Hospital District, Finland reviewed and approved the trial
protocol.
Sample preparations and real-time polymerase chain
reaction (PCR) analysis
We isolated viruses and parasites using nucleic acids
QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany)
from 10% stool suspension. We used real-time PCR to
characterise enterovirus, rotavirus, norovirus, parechovirus
and rhinovirus (13,14), and parasites G. lamblia and
Cryptosporidium species (15). We considered a specimen
as a positive sample if two or three of the triplicate PCR
runs gave a positive test result. We excluded the data if the
actual date of the stool sample was off by plus or minus four
weeks from the prescheduled target date.
Anthropometric indices
Trained research assistants took anthropometric measure-
ments at every three months from the child age of six to
21 months. Assistants measured length using a Kiddimetre
length board (Raven Equipment Ltd., Essex, UK). They
weighed the children using a SECA 735 electronic child
weighing scale (Chasmors Ltd., London, UK). We calcu-
lated length-for-age Z-scores (LAZ) and WLZ using WHO
Child Growth Standards (STATA igrowup package) (16).
We excluded measurement if the actual measurement date
was off by plus or minus four weeks from the target age.
Statistical analysis
For prevalence of viruses and parasites, we calculated
percentages by intervention group as number of positive
samples at each study visit. For LAZ and change in LAZ, we
calculated group means and used least squares regression to
estimate differences between groups. For all time points
combined, we took intragroup correlation due to multiple
measurements per participant into account by using robust
standard errors for clustered data. We rejected a null
hypothesis if two-sided p < 0.05. Prevalence of virus and
parasite by intervention group is presented without covari-
ate adjustment. Analysis of association between virus or
parasite and LAZ and change in LAZ is adjusted for child’s
virus or parasite status at enrolment, maternal height,
maternal body mass index at enrolment, child sex, maternal
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Figure 1 Participant flow.
Table 1 Baseline characteristics of participants at enrolment by intervention group
Participant characteristics
Intervention group
Control Corn-soy blend Milk LNS Soy LNS
Number of participants 175 175 175 181
Infant male sex N (%) 95 (54.3%) 85 (48.6%) 90 (51.4%) 86 (47.5%)
Mean (SD) age, months 6.0 (0.2) 6.0 (0.3) 6.0 (0.2) 6.0 (0.2)
Length, cm 63.0 (2.1) 62.9 (2.2) 62.7 (2.1) 62.7 (2.1)
LAZ 1.73 (0.97) 1.68 (0.97) 1.79 (0.99) 1.80 (0.96)
WLZ 0.39 (0.99) 0.49 (1.07) 0.55 (1.03) 0.41 (1.11)
Socio-economic score† 0.01 (1.04) 0.06 (1.05) 0.02 (0.99) 0.00 (0.92)
Maternal education, years 3.4 (3.2) 4.0 (3.5) 3.0 (3.1) 3.6 (3.1)
Sanitary facilities N (%)
None 13 (7.4%) 6.9%) 12 (6.9%) 11 (6.1%)
Vent. impr. pit latrine 1 (0.6%) 2 (1.1%) 0 (0.0%) 0 (0.0%)
Regular pit latrine 157 (89.7%) 157 (89.7%) 161 (92.0%) 166 (1.7%)
Other/missing 4 (2.3%) 4 (2.3%) 2 (1.1%) 4 (2.2%)
Water source N (%)
Improved
Piped water 6 (3.4%) 11 (6.3%) 6 (3.4%) 8 (4.4%)
Borehole 151 (86.3%) 137 (78.3%) 146 (83.4%) 137 (75.7%)
Protected well 3 (1.7%) 6 (3.4%) 11 (6.3%) 7 (3.9%)
Non-improved
Unprotected well 8 (4.6%) 11 (6.3%) 8 (4.6%) 21 (11.6%)
Lake 3 (1.7%) 5 (2.9%) 1 (0.6%) 6 (3.3%)
River, pond 0 (0.0%) 1 (0.6%) 1 (0.6%) 0 (0.0%)
Other/missing 4 (2.3%) 4 (2.3%) 2 (1.1%) 2 (1.1%)
Data are presented as mean SD, unless otherwise stated.
†Socio-economic score is derived from household assets and housing conditions.
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education, season of visit, enrolment site, water source and
socio-economic score. We performed statistical analyses
using Stata 15.1 (Stata Corp, College Station, TX, USA).
RESULTS
Of the 1312 infants who were identified through commu-
nity census, 472 were either ineligible, or they were not
brought to an enrolment session (Fig. 1). At six months of
age, the mean standard deviation (SD) LAZ of the partic-
ipants was 1.75 (0.97) and the meanWLZ was 0.46 (1.05).
Less than five per cent of the participants had access to a
piped water, and 91% of the participants had a sanitary
facility, a pit latrine. There were no differences in the
background characteristics between the intervention
groups (Table 1).
When all the time points and intervention groups were
combined, the prevalence of testedmicrobes ranged from2.0%
of rotavirus to 75.9% of enterovirus. The percentage of positive
stools forG. lambliabothat sixand12 monthsofagewas6.2%,
the positivity both at 12 and 18 months of age was 10.6% and
the positivity at six, 12 and 18 months of age was 5.1%. There
was no statistically significant association between the dietary
followed by the children and the prevalence of any of the
studied microbes at any age (Table 2).
Because there were no differences in the prevalence of
pathogens between the intervention groups, the subgroups
were combined for the growth analyses. All age groups
combined, children negative forG. lamblia had a mean SD of
0.01 (0.49) change in LAZ, whereas the figure was 0.12
(0.45) among those positive for G. lamblia (difference 0.10,
95% CI 0.21 to 0.00, p = 0.047). The LAZ change
difference was largest and statistically significant (p = 0.042)
between 18 and 21 months of age and smaller and statistically
not significant at earlier time points. Children negative for
rhinovirus at 12 months of age had a mean SD of 0.10
(0.51) change in LAZ, whereas the figure was 0.38 (0.50)
among those positive for rhinovirus (difference 0.27, 95% CI
0.49 to 0.06, p = 0.011). With the exception of rhinovirus
at this time point, the prevalence of other studied viruses was
not associated with the children’s linear growth in the
subsequent three-month period (Table 3).
Generally, there was no association between the micro-
bial prevalence at six, 12 or 18 months and attained LAZ by
the same time point. The only exception was Cryptosporid-
ium detection at 18 months of age when the mean (95% CI)
LAZ was 0.87 (1.64 to 0.10, p = 0.026) units lower
among children with Cryptosporidium in their stool than
those without it (Table 4).
DISCUSSION
The main aim of this study was to analyse if intestinal
presence of G. lamblia, Cryptosporidium species, or
Table 2 The prevalence of virus and parasite at each study visit by intervention group
Visit
Number of positive samples by intervention group (%)
Control CSB Milk LNS Soy LNS p-Value†
Giardia lamblia At enrolment (6 months) 10 (9) 10 (9) 9 (8) 14 (12) 0.764
12 months 21 (29) 15 (19) 18 (22) 17 (22) 0.523
18 months 25 (23) 29 (28) 32 (29) 30 (26) 0.729
Cryptosporidium (spp.) At enrolment (6 months) 5 (5) 8 (7) 7 (7) 6 (5) 0.904
12 months 6 (8) 8 (10) 6 (7) 4 (5) 0.724
18 months 4 (4) 3 (3) 0 (0) 2 (2) 0.201
Enterovirus At enrolment (6 months) 73 (67) 83 (72) 71 (66) 76 (67) 0.823
12 months 58 (79) 61 (76) 64 (78) 68 (87) 0.309
18 months 89 (81) 83 (80) 92 (84) 91 (79) 0.832
Parechovirus At enrolment (6 months) 22 (21) 33 (28) 19 (18) 31 (27) 0.186
12 months 12 (16) 13 (16) 12 (15) 13 (17) 0.986
18 months 20 (18) 16 (15) 19 (17) 18 (16) 0.942
Rotavirus At enrolment (6 months) 3 (3) 4 (3) 4 (4) 4 (4) >0.999
12 months 1 (1) 1 (1) 0 (0) 1 (1) 0.712
18 months 0 (0) 1 (1) 2 (2) 0 (0) 0.279
Norovirus At enrolment (6 months) 18 (17) 28 (24) 29 (27) 26 (23) 0.340
12 months 16 (22) 15 (19) 20 (24) 16 (21) 0.847
18 months 15 (14) 13 (13) 18 (16) 21 (18) 0.635
Rhinovirus At enrolment (6 months) 33 (31) 29 (25) 29 (27) 34 (30) 0.738
12 months 7 (10) 17 (21) 14 (17) 20 (26) 0.065
18 months 31 (28) 37 (36) 41 (37) 29 (25) 0.158
CSB, Corn-soy blend.
Six months: Control N = 106, CSB N = 116, Milk LNS N = 107, Soy LNS N = 114; 12 months: Control N = 73, CSB N = 80, Milk LNS N = 82, Soy LNS
N = 78; 18 months: Control N = 110, CSB N = 104, Milk LNS N = 110, Soy LNS N = 115.
†p-Value obtained with Fisher’s exact test for individual visits.
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enterovirus, rotavirus, norovirus, parechovirus or rhi-
novirus in early childhood is associated with subsequent
growth restriction among children living in Sub-Saharan
resource-poor areas. A secondary aim was to assess if
dietary supplementation with LNS or corn-soy flour would
be associated with microbial detection. In a sample of 840
asymptomatic children aged six to 18 months, there was a
high prevalence of viruses and parasites. Primarily, the
detection of G. lamblia was associated with a growth
restriction in certain three-month periods. Dietary fortifi-
cation with LNS or corn–soy flour was not associated with
the prevalence of the studied viruses or parasites among the
children.
The main possible causes of bias in our study design were
the symptomatic infections and the contamination of the
samples during the laboratory analyses. For this reason, the
guardians recorded on a daily basis the presence or absence
of various illness symptoms. To detect possible contamina-
tion during the laboratory analyses, we used negative
control samples in sample preparation, extraction and
PCR but we found none. Also, the possibility of false
negative results was reduced by the use of the positive
control samples.
The strength of the trial was the high internal validity.
This was due to the random group allocation, blinding of
the outcome assessors and similarity of the intervention
groups at enrolment. The success of faecal sample collec-
tion was relatively low (47.4%) which can be considered as
a limiting factor in the study. However, this should not have
biased our conclusions as the proportions with available
sample were similar in all the intervention groups, also at
12 months of age when we obtained the lowest sample
collection rate. Accordingly, we conclude that the sample
findings are valid and representative of the target popula-
tion from which the sample was drawn.
Of the studied microbes in our study, the presence of
G. lamblia was mainly negatively associated with subse-
quent linear growth among asymptomatic infants and








indicated microbe Difference between groups p-Value‡
Giardia lamblia All ages combined 0.01 (0.49) 0.12 (0.45) 0.10 (0.21, 0.00) 0.047
6–9 months 0.01 (0.48) 0.06 (0.46) 0.05 (0.13, 0.24) 0.581
12–15 months 0.14 (0.51) 0.25 (0.46) 0.11 (0.35, 0.13) 0.364
18–21 months 0.01 (0.50) 0.13 (0.46) 0.14 (0.27, 0.01) 0.042
Cryptosporidium spp. All ages combined 0.03 (0.49) 0.03 (0.43) 0.00 (0.16, 0.16) 0.998
6–9 months 0.02 (0.48) 0.11 (0.45) 0.13 (0.36, 0.10) 0.253
12–15 months 0.17 (0.50) 0.00 (0.44) 0.17 (0.12, 0.47) 0.247
18–21 months 0.03 (0.50) 0.37 (0.43) 0.34 (0.72, 0.04) 0.081
Enterovirus All ages combined 0.03 (0.48) 0.04 (0.49) 0.01 (0.10, 0.08) 0.824
6–9 months 0.01 (0.49) 0.03 (0.48) 0.04 (0.08, 0.17) 0.493
12–15 months 0.07 (0.50) 0.17 (0.50) 0.10 (0.33, 0.14) 0.394
18–21 months 0.02 (0.49) 0.04 (0.49) 0.02 (0.19, 0.15) 0.923
Parechovirus All ages combined 0.04 (0.50) 0.01 (0.44) 0.03 (0.06, 0.13) 0.512
6–9 months 0.02 (0.49) 0.01 (0.46) 0.03 (0.16, 0.11) 0.665
12–15 months 0.18 (0.52) 0.06 (0.45) 0.12 (0.12, 0.35) 0.336
18–21 months 0.05 (0.51) 0.01 (0.45) 0.03 (0.12, 0.18) 0.656
Rotavirus All ages combined 0.04 (0.49) 0.10 (0.41) 0.14 (0.11, 0.39) 0.265
6–9 months 0.01 (0.48) 0.14 (0.39) 0.13 (0.18, 0.44) 0.423
12–15 months NA NA NA NA
18–21 months NA NA NA NA
Norovirus All ages combined 0.04 (0.49) 0.02 (0.47) 0.02 (0.09, 0.12) 0.762
6–9 months 0.02 (0.49) 0.00 (0.46) 0.01 (0.15, 0.12) 0.825
12–15 months 0.16 (0.51) 0.13 (0.51) 0.03 (0.17, 0.24) 0.736
18–21 months 0.04 (0.50) 0.02 (0.49) 0.02 (0.14, 0.19) 0.765
Rhinovirus All ages combined 0.02 (0.48) 0.08 (0.48) 0.07 (0.16, 0.02) 0.136
6–9 months 0.01 (0.48) 0.02 (0.48) 0.01 (0.11, 0.14) 0.830
12–15 months 0.10 (0.51) 0.38 (0.50) 0.27 (0.49, 0.06) 0.011
18–21 months 0.03 (0.49) 0.05 (0.49) 0.02 (0.15, 0.12) 0.818
Adjusted for child’s virus or parasite status at enrolment, maternal height, maternal BMI at enrolment, child sex, maternal education, season of visit (Jan–Mar, Apr–
Jun, Jul–Sep, Oct–Dec), enrolment site, water source and socio-economic score, principal component. All ages combined: N = 686 (N of participants 400). Six to
nine months: N = 352. 12–15 months: N = 131. 18–21 months: N = 203.
†SD for adjusted means estimated from least squares regression.
‡p-Value and 95% CI obtained from least squares regression. For all time points combined, intragroup correlation due to multiple measurements per participant
taken into account by using robust standard errors for clustered data.
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young children. Such an association betweenG. lamblia and
child growth has earlier been identified in cohort studies in
Sub-Saharan Africa, Southern Asia and South America (17).
Although there have also been studies in which this associ-
ation was not found (18,19), the bulk of the evidence seems
to suggest a link between symptomatic or asymptomatic
Giardia infection and reduced linear growth in most low-
income contexts. Such an association is likely to be causal, as
Giardia infections are often chronic (20) and can lead to
prolonged aberrations in gut function and nutrient absorp-
tion (21,22). Additionally, systemic inflammation caused by
chronic infections can interfere the growth hormone –
insulin-like growth factor 1 pathway and reduce growth
plate activity and hence linear growth (21,23).
In our sample, asymptomatic Cryptosporidium spp. carriage
was associated with reduced linear growth only at 18 months
of age.A recentmeta-analysis of data fromsix studies suggested
a linear growth restriction associated both with symptomatic
or asymptomatic Cryptosporidium infection (24).
Short episode duration may be the reason why in most
cases, there was no association between the documented
viral infections and children’s length gain in the subse-
quent three-month period. The excretion of enterovirus,
parechovirus, rotavirus, norovirus and rhinovirus typically
lasts only some days to weeks. Furthermore, viral infec-
tions often elicit an interferon-based host response that
provides short-acting protection also towards other viral
species (25). A single time point assessment of a child’s
viral infection status is thus unlikely to be representative
of her situation over the whole subsequent period of three
months. If this was the case, the use of three-month
follow-up could obscure the importance of viral infections
in linear growth restriction. Few studies have addressed
the association between asymptomatic viral infections and
growth (26,27). To better assess the growth impact of
non-chronic viral infections, one should thus probably
use with a short follow-up period a more sensitive
outcome variable, such as knemometry, plasma
Table 4 The association between virus or parasite and attained LAZ
Virus/parasite Child age







Giardia lamblia All ages combined 1.77 (0.93) 1.86 (0.92) 0.09 (0.26, 0.08) 0.292
6 months 1.68 (0.95) 1.51 (0.94) 0.17 (0.13, 0.46) 0.276
12 months 1.71 (0.94) 1.96 (0.93) 0.25 (0.61, 0.12) 0.182
18 months 2.00 (0.94) 1.91 (0.96) 0.17 (0.09, 0.44) 0.201
Cryptosporidium spp. All ages combined 1.79 (0.92) 1.67 (0.99) 0.13 (0.20, 0.45) 0.450
6 months 1.65 (0.95) 1.87 (1.03) 0.22 (0.60, 0.15) 0.244
12 months 1.80 (0.94) 1.35 (1.01) 0.45 (0.11, 1.01) 0.113
18 months 2.00 (0.94) 2.87 (0.99) 0.87 (1.64, 0.10) 0.026
Enterovirus All ages combined 1.76 (0.93) 1.79 (0.93) 0.03 (0.18, 0.12) 0.683
6 months 1.66 (0.93) 1.66 (0.96) 0.00 (0.19, 0.19) 0.974
12 months 1.88 (0.95) 1.73 (0.94) 0.15 (0.21, 0.51) 0.421
18 months 1.99 (0.94) 2.02 (0.95) 0.03 (0.35, 0.29) 0.859
Parechovirus All ages combined 1.77 (0.93) 1.83 (0.90) 0.06 (0.21, 0.09) 0.456
6 months 1.66 (0.96) 1.68 (0.90) 0.31 (0.24, 0.18) 0.803
12 months 1.74 (0.95) 1.89 (0.91) 0.15 (0.56, 0.25) 0.456
18 months 2.04 (0.95) 1.95 (0.92) 0.09 (0.21, 0.39) 0.554
Rotavirus All ages combined 1.79 (0.93) 1.50 (0.80) 0.30 (0.26, 0.86) 0.299
6 months 1.66 (0.95) 1.62 (0.75) 0.05 (0.43, 0.52) 0.847
12 months 1.76 (0.94) 1.66 (0.87) 0.10 (1.86, 2.06) 0.919
18 months 2.01 (0.95) 3.34 (0.81) 1.32 (3.32, 0.68) 0.193
Norovirus All ages combined 1.78 (0.94) 1.81 (0.86) 0.03 (0.19, 0.13) 0.670
6 months 1.63 (0.96) 1.77 (0.93) 0.14 (0.35, 0.07) 0.193
12 months 1.77 (0.96) 1.73 (0.86) 0.04 (0.31, 0.38) 0.828
18 months 2.00 (0.95) 2.10 (0.91) 0.10 (0.42, 0.22) 0.532
Rhinovirus All ages combined 1.77 (0.92) 1.83 (0.95) 0.07 (0.24, 0.11) 0.462
6 months 1.65 (0.95) 1.71 (0.96) 0.06 (0.25, 0.13) 0.540
12 months 1.76 (0.93) 1.80 (0.96) 0.05 (0.43, 0.33) 0.797
18 months 2.00 (0.93) 2.06 (0.97) 0.05 (0.31, 0.21) 0.696
Adjusted for child’s virus or parasite status at enrolment, maternal height, maternal BMI at enrolment, child sex, maternal education, season of visit (Jan–Mar, Apr–
Jun, Jul–Sep, Oct–Dec), enrolment site, water source and socio-economic score. All ages combined: N = 861 (N of participants 451). Six months: N = 426.
12 months: N = 190. 18 months: N = 245.
†SD for adjusted means estimated from least squares regression.
‡p-Value and 95% CI obtained from least squares regression. For all time points combined, intragroup correlation due to multiple measurements per participant
taken into account by using robust standard errors for clustered data.
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concentrations of insulin-like growth factor or collagen X
(21,28,29).
The finding of no association between the dietary
supplement given to the children and detection of selected
microbes in the children’s stool is not surprising, since diet
has not been reported to significantly influence viral
propagation in children who are not malnourished. The
result is also in line with an earlier intervention study, in
which provision of LNS to children with severe acute
malnutrition was not associated with a change in the
detected virome in the children’s stools (30). In a previously
published research on the same study sample, the dietary
intervention was not either associated with the composition
of the children’s microbiota (10).
Taken together, our results suggest that asymptomatic
G. lamblia infections may restrict child growth in low-income
settings such as rural Malawi. As a conclusion, asymptomatic
viral infections are common and may also influence growth,
but more refined measurement of growth or growth-related
activity is necessary to better elucidate this question.
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